Dr Rob Kozma

Rob trained as a scientist, in molecular and cell biology, and genetics, obtaining his PhD at Edinburgh University. He spent time at University College London and the Institute of Neurology researching signal transduction in cell development, discovering novel pathways involved in neural development and cancer.

He worked for GSK in the area of preclinical target development, and has published over 40 scientific papers and book chapters, as well as presenting seminars at numerous international conferences.

He worked in Guy’s Hospital developing cutting-edge cellular and genetic prenatal diagnostic methods.

Rob was also a senior scientist at the Institute of Molecular and Cell Biology in Singapore. He helped develop several incubation and spin-off companies in the UK as well as in Singapore, and obtained an MBA at Imperial College. While in Singapore he was a founding member of Exploit Technologies and the Industry Development Group of A*STAR (Agency for Science, Technology and Research) and helped build the business development function at the Genome Institute of Singapore.

More recently he has acted as principal consultant for several biotechnology and diagnostics companies; consulted for investment groups; developed a marketing strategy using big data analysis for the healthcare and pharmaceutical sectors; and consulted for the National University Hospital Singapore on matters of intellectual property, clinical trials and global alliances.

Rob joined CEC in 2018 and became a partner in 2019.